Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 43,600 shares, a decrease of 62.4% from the December 15th total of 116,100 shares. Based on an average daily trading volume, of 1,160,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 3.2% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Arcadia Biosciences in a research note on Friday. They issued a “sell” rating for the company.

Check Out Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Price Performance

NASDAQ:RKDA traded up $0.05 during trading hours on Tuesday, reaching $4.90. 5,647 shares of the stock were exchanged, compared to its average volume of 25,206. The firm has a 50 day moving average of $4.72 and a 200 day moving average of $3.63. The stock has a market cap of $6.69 million, a PE ratio of -1.14 and a beta of 0.90. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Featured Articles

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.